サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605885

ウイルス増感剤市場、規模、シェア、動向、産業分析レポート：用途別、エンドユーザー別、地域別 - 市場予測 2025年～2034年

Viral Sensitizers Market Size, Share, Trends, Industry Analysis Report: By Application, End Users, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ウイルス増感剤市場、規模、シェア、動向、産業分析レポート：用途別、エンドユーザー別、地域別 - 市場予測 2025年～2034年
出版日: 2024年11月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、ウイルス増感剤の市場規模は2034年までに79億5,080万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ウイルス増感剤市場とは、ウイルスを治療に対して感受性を高めることで、抗ウイルス治療やワクチンの有効性を高める化合物や薬剤の市場を指します。これらの増感剤は、特にHIV、肝炎、がん関連ウイルスなどのウイルス感染症の治療において、耐性メカニズムを克服し、治療成績を向上させるのに役立ちます。

ウイルス増感剤市場は、腫瘍学や感染症治療における需要の高まりにより、著しい成長を遂げています。主な促進要因としては、免疫療法の進歩、がん罹患率の増加、革新的な治療アプローチの必要性などが挙げられます。化学療法や放射線療法などの既存の治療法の有効性を高めるウイルス増感剤の開発にビジネスチャンスが生まれています。予測される動向は、標的ウイルス療法と個別化医療への注目の高まりを示しており、プレシジョン・ヘルスケアの広範な推進と一致しています。全体として、バイオテクノロジー企業とヘルスケアプロバイダーの間で進行中の調査や共同研究によって、市場の拡大が見込まれています。

ウイルス増感剤市場レポートハイライト

用途別分析では、抗ウイルス薬開発分野が市場を独占しており、新興ウイルス感染に対する世界の懸念の高まりから、最速の成長が見込まれています。

エンドユーザー別では、製薬企業とバイオテクノロジー企業が市場をリードしており、広範な研究開発投資とパートナーシップの恩恵を受けています。研究機関は、ウイルス療法研究と臨床試験のための資金増加により、急成長が予測されます。

北米は、高度なヘルスケア・インフラと高い研究開発費により、最大の市場シェアを占めています。アジア太平洋は、ヘルスケア投資の増加とバイオテクノロジー分野の拡大により、最も急成長している地域です。

ウイルス増感剤市場の主要企業には、Gilead Sciences, Pfizer, Merck & Co., and Johnson & Johnson.が含まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のウイルス増感剤市場の洞察

  • 市場スナップショット
  • ウイルス増感剤市場力学
    • 促進要因と機会
      • 併用療法の統合
      • 精密医療の進歩
    • 抑制要因と課題
      • 市場認知度の低さ
  • PESTEL分析
  • ウイルス増感剤市場の応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のウイルス増感剤市場：用途別

  • 主な調査結果
  • イントロダクション
  • 抗ウイルス薬の開発
  • ワクチン開発
  • 腫瘍溶解性ウイルス療法

第6章 世界のウイルス増感剤市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 製薬会社
  • バイオテクノロジー企業
  • 調査機関
  • その他

第7章 世界のウイルス増感剤市場：地域別

  • 主な調査結果
  • イントロダクション
    • ウイルス増感剤市場評価：地域、2020～2034年
  • 北米
    • 北米：用途別、2020～2034年
    • 北米：エンドユーザー別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：用途別、2020～2034年
    • 欧州：エンドユーザー別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：用途別、2020～2034年
    • アジア太平洋地域：エンドユーザー別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：用途別、2020～2034年
    • 中東・アフリカ：エンドユーザー別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：用途別、2020～2034年
    • ラテンアメリカ：エンドユーザー別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Gilead Sciences
  • Pfizer
  • Merck & Co.
  • Johnson & Johnson
  • AbbVie
  • Bristol-Myers Squibb
  • Roche
  • Moderna
  • AstraZeneca
  • Alnylam Pharmaceuticals
  • Iovance Biotherapeutics
  • Cellectis
  • Bluebird Bio
  • Regeneron Pharmaceuticals
図表

List of Tables:

  • Table 1 Global Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 2 Global Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 3 North America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 4 North America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 5 U.S.: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 6 U.S.: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 7 Canada: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 8 Canada: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 9 Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 10 Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 11 UK: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 12 UK: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 13 France: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 14 France: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 15 Germany: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 16 Germany: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 17 Italy: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 18 Italy: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 19 Spain: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 20 Spain: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 21 Netherlands: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 22 Netherlands: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 23 Russia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 24 Russia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 29 China: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 30 China: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 31 India: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 32 India: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 33 Malaysia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 34 Malaysia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 35 Japan: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 36 Japan: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 37 Indonesia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 38 Indonesia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 39 South Korea: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 40 South Korea: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 41 Australia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 42 Australia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 49 UAE: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 50 UAE: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 51 Israel: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 52 Israel: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 53 South Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 54 South Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 57 Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 58 Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 59 Mexico: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 60 Mexico: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 61 Brazil: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 62 Brazil: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 63 Argentina: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 64 Argentina: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Viral Sensitizers Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Viral Sensitizers Market, by Application, 2024 & 2034 (USD Million)
  • Figure 8. Market by End User
  • Figure 9. Global Viral Sensitizers Market, by End User, 2024 & 2034 (USD Million)
目次
Product Code: PM5231

The viral sensitizers market size is expected to reach USD 7,950.80 million by 2034, according to a new study by Polaris Market Research. The report "Viral Sensitizers Market Size, Share, Trends, Industry Analysis Report: By Application (Antiviral Drug Development, Vaccine Development, and Oncolytic Viral Therapies), End Users, and By Region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The viral sensitizers market refers to the market for compounds or agents that enhance the efficacy of antiviral treatments or vaccines by making viruses more susceptible to the therapies. These sensitizers helps to overcome resistance mechanisms and improve therapeutic outcomes, particularly in treating viral infections like HIV, hepatitis, and cancer-related viruses.

The viral sensitizers market is witnessing significant growth due to rising demand in oncology and infectious disease treatment. Key drivers include advancements in immunotherapy, increasing cancer prevalence, and the need for innovative treatment approaches. Opportunities are emerging in the development of viral sensitizers that enhance the efficacy of existing therapies, such as chemotherapy and radiotherapy. Anticipated trends show a growing focus on targeted viral therapies and personalized medicine, aligning with the broader push for precision healthcare. Overall, the market is expected to expand, fueled by ongoing research and collaborations between biotech firms and healthcare providers.

Viral Sensitizers Market Report Highlights

By application analysis, the antiviral drug development segment dominates the market, and is also expected to witness the fastest growth due to increasing global concerns over emerging viral infections.

By end users analysis, pharmaceutical and biotechnology companies lead the market, benefiting from extensive R&D investments and partnerships. Research institutes are projected to grow rapidly due to increased funding for viral therapy research and clinical trials.

North America holds the largest market share, owing to advanced healthcare infrastructure and high R&D spending. Asia Pacific is the fastest-growing region, driven by rising healthcare investments and expanding biotechnology sectors.

Key players in the viral sensitizers market include Gilead Sciences, Pfizer, Merck & Co., and Johnson & Johnson.

Polaris market research has segmented the viral sensitizers market report based on application, end users, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

  • Antiviral Drug Development
  • Vaccine Development
  • Oncolytic Viral Therapies

By End Users Outlook (Revenue - USD Million, 2020-2034)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Viral Sensitizers Market Insights

  • 4.1. Viral Sensitizers Market - Market Snapshot
  • 4.2. Viral Sensitizers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of Combination Therapies
      • 4.2.1.2. Advancements in Precision Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Market Awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Viral Sensitizers Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Viral Sensitizers Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  • 5.3. Antiviral Drug Development
    • 5.3.1. Global Viral Sensitizers Market, by Antiviral Drug Development, by Region, 2020-2034 (USD Million)
  • 5.4. Vaccine Development
    • 5.4.1. Global Viral Sensitizers Market, by Vaccine Development, by Region, 2020-2034 (USD Million)
  • 5.5. Oncolytic Viral Therapies
    • 5.5.1. Global Viral Sensitizers Market, by Oncolytic Viral Therapies, by Region, 2020-2034 (USD Million)

6. Global Viral Sensitizers Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • 6.3. Pharmaceutical Companies
    • 6.3.1. Global Viral Sensitizers Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Million)
  • 6.4. Biotechnology Companies
    • 6.4.1. Global Viral Sensitizers Market, by Biotechnology Companies, by Region, 2020-2034 (USD Million)
  • 6.5. Research Institutes
    • 6.5.1. Global Viral Sensitizers Market, by Research Institutes, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Viral Sensitizers Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Viral Sensitizers Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Viral Sensitizers Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Viral Sensitizers Market - North America
    • 7.3.1. North America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
    • 7.3.2. North America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.3.3. Viral Sensitizers Market - U.S.
      • 7.3.3.1. U.S.: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.3.3.2. U.S.: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.3.4. Viral Sensitizers Market - Canada
      • 7.3.4.1. Canada: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • 7.4. Viral Sensitizers Market - Europe
    • 7.4.1. Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
    • 7.4.2. Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.3. Viral Sensitizers Market - UK
      • 7.4.3.1. UK: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.4. Viral Sensitizers Market - France
      • 7.4.4.1. France: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.4.2. France: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.5. Viral Sensitizers Market - Germany
      • 7.4.5.1. Germany: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.6. Viral Sensitizers Market - Italy
      • 7.4.6.1. Italy: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.7. Viral Sensitizers Market - Spain
      • 7.4.7.1. Spain: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.8. Viral Sensitizers Market - Netherlands
      • 7.4.8.1. Netherlands: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.9. Viral Sensitizers Market - Russia
      • 7.4.9.1. Russia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.4.10. Viral Sensitizers Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • 7.5. Viral Sensitizers Market - Asia Pacific
    • 7.5.1. Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.3. Viral Sensitizers Market - China
      • 7.5.3.1. China: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.3.2. China: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.4. Viral Sensitizers Market - India
      • 7.5.4.1. India: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.4.2. India: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.5. Viral Sensitizers Market - Malaysia
      • 7.5.5.1. Malaysia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.6. Viral Sensitizers Market - Japan
      • 7.5.6.1. Japan: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.7. Viral Sensitizers Market - Indonesia
      • 7.5.7.1. Indonesia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.8. Viral Sensitizers Market - South Korea
      • 7.5.8.1. South Korea: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.9. Viral Sensitizers Market - Australia
      • 7.5.9.1. Australia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.5.10. Viral Sensitizers Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • 7.6. Viral Sensitizers Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.6.3. Viral Sensitizers Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.6.4. Viral Sensitizers Market - UAE
      • 7.6.4.1. UAE: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.6.5. Viral Sensitizers Market - Israel
      • 7.6.5.1. Israel: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.6.6. Viral Sensitizers Market - South Africa
      • 7.6.6.1. South Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.6.7. Viral Sensitizers Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
  • 7.7. Viral Sensitizers Market - Latin America
    • 7.7.1. Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.7.3. Viral Sensitizers Market - Mexico
      • 7.7.3.1. Mexico: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.7.4. Viral Sensitizers Market - Brazil
      • 7.7.4.1. Brazil: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.7.5. Viral Sensitizers Market - Argentina
      • 7.7.5.1. Argentina: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
    • 7.7.6. Viral Sensitizers Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Gilead Sciences
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Pfizer
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Merck & Co.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Johnson & Johnson
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. AbbVie
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Bristol-Myers Squibb
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Roche
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Moderna
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. AstraZeneca
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Alnylam Pharmaceuticals
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Iovance Biotherapeutics
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Cellectis
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Bluebird Bio
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Regeneron Pharmaceuticals
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development